Tenchov R, Sasso JM, Zhou QA. PEGylated lipid nanoparticle formulations: immunological safety and efficiency perspective. Bioconjug Chem. 2023;34(6):941–60. https://doi.org/10.1021/acs.bioconjchem.3c00174.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Poovi G, Damodharan N. Development of tamoxifen-loaded surface-modified nanostructured lipid carrier using experimental design: in vitro and ex vivo characterisation. IET Nanobiotechnol. 2020;14(4):261–74. https://doi.org/10.1049/iet-nbt.2019.0276.

Article  PubMed  PubMed Central  Google Scholar 

Wolkersdorfer AM, Jugovic I, Scheller L, Gutmann M, Hahn L, Diessner J, Lühmann T, Meinel L. PEGylation of human vascular endothelial growth factor. ACS Biomater Sci Eng. 2024;10(1):149–55. https://doi.org/10.1021/acsbiomaterials.3c00253.

Article  CAS  PubMed  Google Scholar 

Zuma LK, Gasa NL, Makhoba XH, Pooe OJ. Protein PEGylation: navigating recombinant protein stability, aggregation, and bioactivity. BioMed Res Int. 2022;2022:8929715. https://doi.org/10.1155/2022/8929715.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shimabukuro T, Nair N. Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine. J Am Med Assoc. 2021;325(8):780–1. https://doi.org/10.1001/jama.2021.0600.

Article  CAS  Google Scholar 

Moghimi SM. Allergic reactions and anaphylaxis to LNP-based COVID-19 vaccines. Mol Ther. 2021;29(3):898–900. https://doi.org/10.1016/j.ymthe.2021.01.030.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Torjesen I. Covid-19: Norway investigates 23 deaths in frail elderly patients after vaccination. BMJ. 2021;372:n149. https://doi.org/10.1136/bmj.n149.

Article  PubMed  Google Scholar 

Cox F, Khalib K, Conlon N. PEG that reaction: a case series of allergy to polyethylene glycol. BMJ. 2021;61(6):832–5. https://doi.org/10.1002/jcph.1824.

Article  CAS  Google Scholar 

Zalba S, Ten Hagen TLM, Burgui C, Garrido MJ. Stealth nanoparticles in oncology: facing the PEG dilemma. J Control Release. 2022;351:22–36. https://doi.org/10.1016/j.jconrel.2022.09.002.

Article  CAS  PubMed  Google Scholar 

Elgamal HA, Mohamed SA, Farghali AA, Hassan AME. PEG@ Carbon nanotubes composite as an effective nanocarrier of ixazomib for myeloma cancer therapy. Nanoscale Res Lett. 2022;17(1):72. https://doi.org/10.1186/s11671-022-03707-2.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Alavi SE, KoohiMoftakhari Esfahani M, Raza A, Adelnia H, Ebrahimi Shahmabadi H. PEG-grafted liposomes for enhanced antibacterial and antibiotic activities: an in vivo study. NanoImpact. 2022;25:100384. https://doi.org/10.1016/j.impact.2022.100384.

Article  CAS  PubMed  Google Scholar 

Deuker MFS, Mailänder V, Morsbach S, Landfester K. Anti-PEG antibodies enriched in the protein corona of PEGylated nanocarriers impact the cell uptake. Nanoscale Horiz. 2023;17:1377–85. https://doi.org/10.1039/d3nh00198a.

Article  ADS  CAS  Google Scholar 

Okada N, Taro S, Ando H, Nakamura S, Goda M, Abe M, Kitahara T, Ishida T, Ishizawa K. Clinical impact of antipolyethylene glycol (PEG) antibody in hematological patients administered pegylated-granulocyte colony-stimulating factor. Clin Pharmacol Drug Dev. 2023;12(8):826–31. https://doi.org/10.1002/cpdd.1225.

Article  CAS  PubMed  Google Scholar 

Bavli Y, Chen BM, Gross G, Hershko A, Turjeman K, Roffler S, Barenholz Y. Anti-PEG antibodies before and after a first dose of Comirnaty® (mRNA-LNP-based SARS-CoV-2 vaccine). J Control Release. 2023;354:316–22. https://doi.org/10.1016/j.jconrel.2022.12.039.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen WA, Chang DY, Chen BM, Lin YC, Barenholz Y, Roffler SR. Antibodies against poly(ethylene glycol) activate innate immune cells and induce hypersensitivity reactions to PEGylated nanomedicines. ACS Nano. 2023;17(6):5757–72. https://doi.org/10.1021/acsnano.2c12193.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Elsadek NE, Emam SE, Abu Lila AS, Shimizu T, Ando H, Ishima Y, Ishida T. Pegfilgrastim (PEG-G-CSF) induces anti-polyethylene glycol (PEG) IgM via a T cell-dependent mechanism. Biol Pharm Bull. 2020;43(9):1393–7. https://doi.org/10.1248/bpb.b20-00345.

Article  CAS  PubMed  Google Scholar 

Weis-Garcia F, Carnahan RH. Characterizing antibodies Cold Spring Harb Protoc. 2017;11:857–69. https://doi.org/10.1101/pdb.top093823.

Article  Google Scholar 

Zhou ZH, Stone CA, Jakubovic B, Phillips EJ, Sussman G, Park J, Hoang U, Kirshner SL, Levin R, Kozlowski S. Anti-PEG IgE in anaphylaxis associated with polyethylene glycol. J Allergy Clin Immunol Pract. 2021;9(4):1731–3. https://doi.org/10.1016/j.jaip.2020.11.011.

Article  CAS  PubMed  Google Scholar 

Zhang Z, Chu Y, Li C, Tang W, Qian J, Wei X, Lu W, Ying T, Zhan C. Anti-PEG scFv corona ameliorates accelerated blood clearance phenomenon of PEGylated nanomedicines. J Control Release. 2021;330:493–501. https://doi.org/10.1016/j.jconrel.2020.12.047.

Article  CAS  PubMed  Google Scholar 

Subasic CN, Butcher NJ, Minchin RF, Kaminskas LM. Dose-dependent production of anti-PEG IgM after intramuscular PEGylated-hydrogenated soy phosphatidylcholine liposomes, but not lipid nanoparticle formulations of DNA, correlates with the plasma clearance of pegylated liposomal doxorubicin in rats. Mol Pharm. 2023;20(7):3494–504. https://doi.org/10.1021/acs.molpharmaceut.3c00104.

Article  CAS  PubMed  Google Scholar 

Mima Y, Hashimoto Y, Shimizu T, Kiwada H, Ishida T. Anti-PEG IgM is a major contributor to the accelerated blood clearance of polyethylene glycol-conjugated protein. Mol Pharm. 2015;12(7):2429–35. https://doi.org/10.1021/acs.molpharmaceut.5b00144.

Article  CAS  PubMed  Google Scholar 

Liu M, Chu Y, Liu H, Su Y, Zhang Q, Jiao J, Liu M, Ding J, Liu M, Hu Y, Dai Y, Zhang R, Liu X, Deng Y, Song Y. Accelerated blood clearance of nanoemulsions modified with PEG-cholesterol and PEG-phospholipid derivatives in rats: the effect of PEG-lipid linkages and PEG molecular weights. Mol Pharm. 2020;17(4):1059–70. https://doi.org/10.1021/acs.molpharmaceut.9b00770.

Article  CAS  PubMed  Google Scholar 

Suzuki T, Suzuki Y, Hihara T, Kubara K, Kondo K, Hyodo K, Yamazaki K, Ishida T, Ishihara H. PEG shedding-rate-dependent blood clearance of PEGylated lipid nanoparticles in mice: faster PEG shedding attenuates anti-PEG IgM production. Int J Pharm. 2020;588:119792. https://doi.org/10.1016/j.ijpharm.2020.119792.

Article  CAS  PubMed  Google Scholar 

Liu M, Zhao D, Yan N, Li J, Zhang H, Liu M, Tang X, Liu X, Deng Y, Song Y, Zhao X. Evasion of the accelerated blood clearance phenomenon by branched PEG lipid derivative coating of nanoemulsions. Int J Pharm. 2022;612:121365. https://doi.org/10.1016/j.ijpharm.2021.121365.

Article  CAS  PubMed  Google Scholar 

Dézsi L, Fülöp T, Mészáros T, Szénási G, Urbanics R, Vázsonyi C, Örfi E, Rosivall L, Nemes R, Kok RJ, Metselaar JM, Storm G, Szebeni J. Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: comparison of the porcine and rat responses. J Control Release. 2014;195:2–10. https://doi.org/10.1016/j.jconrel.2014.08.009.

Article  CAS  PubMed  Google Scholar 

Chiang V, Kan A, Yeung H, Au E, Lau CS, Li PH. Polyethylene glycol allergy: risks of skin testing and complement-mediated anaphylaxis. J Investig Allergol Clin Immunol. 2023;33(1):71–3. https://doi.org/10.18176/jiaci.0813.

Article  CAS  PubMed  Google Scholar 

Pawliczak R. Alergologia-kompendium. Poznan: Termedia; 2013.

Inoue T, Griffin DM, Huq R, Samuel EL, Ruano SH, Stinnett G, Majid TJ, Beeton C, Tour JM, Pautler RG. Characterization of a novel MR-detectable nanoantioxidant that mitigates the recall immune response. NMR Biomed. 2016;29(10):1436–44. https://doi.org/10.1002/nbm.3565.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Haddad HF, Burke JA, Scott EA, Ameer GA. Clinical relevance of pre-existing and treatment-induced anti-poly(ethylene glycol) antibodies. Regen Eng Transl Med. 2022;8(1):32–42. https://doi.org/10.1007/s40883-021-00198-y.

Article  CAS  Google Scholar 

Bent RK, Faihs V, Tizek L, Biedermann T, Zink A, Brockow K. PEG allergy – a COVID-19 pandemic-made problem? A German perspective. World Allergy Organ J. 2022;15(11):100714. https://doi.org/10.1016/j.waojou.2022.100714.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stone BD. PEG skin testing for COVID-19 vaccine allergy. J Allergy Clin Immunol Pract. 2021;9(4):1765. https://doi.org/10.1016/j.jaip.2021.02.016.

Article  CAS  PubMed  PubMed Central  Google Scholar 

D’souza AA, Shegokar R. Polyethylene glycol (PEG): a versatile polymer for pharmaceutical applications. Expert Opin Drug Deliv. 2016;13(9):1257–75. https://doi.org/10.1080/17425247.2016.1182485.

Article  CAS  PubMed